Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Prevalence and clinical profiles of 'autoantibody-negative' systemic sclerosis subjects.

Hudson M, Satoh M, Chan JY, Tatibouet S, Mehra S, Baron M, Fritzler M; Canadian Scleroderma Research Group..

Clin Exp Rheumatol. 2014 Nov-Dec;32(6 Suppl 86):S-127-32. Epub 2013 Oct 21.

PMID:
24144389
2.

Prevalence and clinical associations of anti-Ku antibodies in patients with systemic sclerosis: a European EUSTAR-initiated multi-centre case-control study.

Rozman B, Cucnik S, Sodin-Semrl S, Czirják L, Varjú C, Distler O, Huscher D, Aringer M, Steiner G, Matucci-Cerinic M, Guiducci S, Stamenkovic B, Stankovic A, Kveder T.

Ann Rheum Dis. 2008 Sep;67(9):1282-6. Epub 2007 Dec 6.

PMID:
18063672
3.

Antibodies to RNA polymerase III in systemic sclerosis detected by ELISA.

Santiago M, Baron M, Hudson M, Burlingame RW, Fritzler MJ.

J Rheumatol. 2007 Jul;34(7):1528-34. Epub 2007 Jun 15.

PMID:
17610318
4.

Clinical significance of coexisting antitopoisomerase I and anticentromere antibodies in patients with systemic sclerosis: a EUSTAR group-based study.

Heijnen IA, Foocharoen C, Bannert B, Carreira PE, Caporali R, Smith V, Kumánovics G, Becker MO, Vanthuyne M, Simsek I, Bocelli-Tyndall C, Walker UA.

Clin Exp Rheumatol. 2013 Mar-Apr;31(2 Suppl 76):96-102. Epub 2012 Oct 24.

PMID:
23101460
5.

Autoantibodies to the Rpp25 component of the Th/To complex are the most common antibodies in patients with systemic sclerosis without antibodies detectable by widely available commercial tests.

Mahler M, Satoh M, Hudson M, Baron M, Chan JY, Chan EK, Wick J, Fritzler MJ; Canadian Scleroderma Research Group..

J Rheumatol. 2014 Jul;41(7):1334-43. doi: 10.3899/jrheum.131450. Epub 2014 Jun 15.

PMID:
24931955
6.

Detection of anti-U3-RNP/fibrillarin IgG antibodies by line immunoblot assay has comparable clinical significance to immunoprecipitation testing in systemic sclerosis.

Peterson LK, Jaskowski TD, Mayes MD, Tebo AE.

Immunol Res. 2016 Apr;64(2):483-8. doi: 10.1007/s12026-015-8710-9.

PMID:
26467972
7.

Specific anti-nuclear antibodies in systemic sclerosis patients with and without skin involvement: an extended methodological approach.

Van Praet JT, Van Steendam K, Smith V, De Bruyne G, Mimori T, Bonroy C, Elewaut D, Deforce D, De Keyser F.

Rheumatology (Oxford). 2011 Jul;50(7):1302-9. doi: 10.1093/rheumatology/keq446. Epub 2011 Feb 17.

PMID:
21330340
8.

Systemic sclerosis in Argentina: evaluation of a large cohort from a single centre and comparison with other international series.

Scolnik M, Lancioni E, Saucedo C, Marin J, Sabelli M, Bedran Z, Soriano ER, Catoggio LJ.

Clin Exp Rheumatol. 2014 Nov-Dec;32(6 Suppl 86):S-94-7. Epub 2014 Sep 8.

PMID:
25198424
9.

Analysis of human sera that are polyreactive in an addressable laser bead immunoassay.

Fritzler MJ, Behmanesh F, Fritzler ML.

Clin Immunol. 2006 Sep;120(3):349-56. Epub 2006 Apr 27.

PMID:
16644287
10.

Novel diagnostic and clinical aspects of anti-PCNA antibodies detected by novel detection methods.

Mahler M, Silverman ED, Fritzler MJ.

Lupus. 2010 Nov;19(13):1527-33. doi: 10.1177/0961203310375265. Epub 2010 Jul 20.

PMID:
20647252
11.

Comparison of indirect immunofluorescence and multiplex antinuclear antibody screening in systemic sclerosis.

Shanmugam VK, Swistowski DR, Saddic N, Wang H, Steen VD.

Clin Rheumatol. 2011 Oct;30(10):1363-8. doi: 10.1007/s10067-011-1766-6. Epub 2011 May 27.

12.

Clinical differences between Thai systemic sclerosis patients with positive versus negative anti-topoisomerase I.

Foocharoen C, Suwannachat P, Netwijitpan S, Mahakkanukrauh A, Suwannaroj S, Nanagara R; Scleroderma Research Group..

Int J Rheum Dis. 2016 Mar;19(3):312-20. doi: 10.1111/1756-185X.12492. Epub 2014 Oct 8.

PMID:
25293362
13.

Anti-Th/To are common antinucleolar autoantibodies in Italian patients with scleroderma.

Ceribelli A, Cavazzana I, Franceschini F, Airò P, Tincani A, Cattaneo R, Pauley BA, Chan EK, Satoh M.

J Rheumatol. 2010 Oct;37(10):2071-5. doi: 10.3899/jrheum.100316. Epub 2010 Aug 3.

PMID:
20682663
14.

Application of anti-DFS70 antibody and specific autoantibody test algorithms to patients with the dense fine speckled pattern on HEp-2 cells.

Lee H, Kim Y, Han K, Oh EJ.

Scand J Rheumatol. 2016;45(2):122-8. doi: 10.3109/03009742.2015.1060260. Epub 2015 Dec 7.

PMID:
26643611
15.

Systemic sclerosis sine scleroderma: a multicenter study of 1417 subjects.

Diab S, Dostrovsky N, Hudson M, Tatibouet S, Fritzler MJ, Baron M, Khalidi N; Canadian Scleroderma Research Group..

J Rheumatol. 2014 Nov;41(11):2179-85. doi: 10.3899/jrheum.140236. Epub 2014 Oct 1.

PMID:
25274885
16.

Clinical performance evaluation of a novel rapid response chemiluminescent immunoassay for the detection of autoantibodies to extractable nuclear antigens.

Bentow C, Swart A, Wu J, Seaman A, Manfredi M, Infantino M, Benucci M, Lakos G, Mahler M.

Clin Chim Acta. 2013 Sep 23;424:141-7. doi: 10.1016/j.cca.2013.05.011. Epub 2013 May 30.

17.

Progression of nailfold microvascular damage and antinuclear antibody pattern in systemic sclerosis.

Sulli A, Ruaro B, Smith V, Pizzorni C, Zampogna G, Gallo M, Cutolo M.

J Rheumatol. 2013 May;40(5):634-9. doi: 10.3899/jrheum.121089. Epub 2013 Mar 1.

PMID:
23457379
18.

Interpretation of an Extended Autoantibody Profile in a Well-Characterized Australian Systemic Sclerosis (Scleroderma) Cohort Using Principal Components Analysis.

Patterson KA, Roberts-Thomson PJ, Lester S, Tan JA, Hakendorf P, Rischmueller M, Zochling J, Sahhar J, Nash P, Roddy J, Hill C, Nikpour M, Stevens W, Proudman SM, Walker JG.

Arthritis Rheumatol. 2015 Dec;67(12):3234-44. doi: 10.1002/art.39316.

19.

A cross-sectional study of autoantibody profiles in the Waikato systemic sclerosis cohort, New Zealand.

Chang WS, Schollum J, White DH, Solanki KK.

Clin Rheumatol. 2015 Nov;34(11):1921-7. doi: 10.1007/s10067-015-2981-3. Epub 2015 May 29.

PMID:
26022620
20.

Performance of a multiplex assay compared to enzyme and precipitation methods for anti-ENA testing in systemic lupus and systemic sclerosis.

Albon S, Bunn C, Swana G, Karim Y.

J Immunol Methods. 2011 Feb 28;365(1-2):126-31. doi: 10.1016/j.jim.2010.12.010. Epub 2010 Dec 22.

PMID:
21184759

Supplemental Content

Support Center